Investigations
Corporate business ethics and investors’ interests have swept aside the humanitarian foundation of American medicine and most of related healthcare, and caring service professions.
Colonel Coots: "It is a significant breach of academic protocol. It’s a breach of trust."
"William Weeks, MD a professor of psychiatry and community and family medicine is facing federal conflict of interest charges" involving contract between the Veterans Affairs department and Dartmouth.
Sen. Charles Grassley’s focused investigation is clearly aimed at cleansing fraudulent, industry-crafted promotional pieces that have made a mockery of evidence-based clinical practice in psychiatry.
The New York Times reports that Federal prosecutors have issued a subpoena seeking information and all documents including transcripts of their testimony produced in litigation relating to three prominent Harvard researchers…
The most shocking disclosure: a Biederman study testing the use of powerful antipsychotics in PRESCHOOL CHILDREN "was beset by breaches of research protocol."
A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing division-provide a bird’s eye view of collusion between the drug giant and Harvard’s leading child psychiatrist, Dr. Joseph Biederman, and one of Harvard’s premier teaching hospitals, Massachusetts General Hospital.
The Guardian reports that the Serious Fraud Office has launched an investigation into allegations that a number of major UK-based firms paid bribes to Saddam Hussein's regime in Iraq.
In sentencing William French Anderson, the judge said: "Because of intellectual arrogance, he persisted and he got away with as much as he could."
“No general counsel or CEO wants to have to explain to his board why the company's name is appearing on the front page of a news article in a scandal…"
OHRP Investigation of experimental treatment for Acute Respiratory Distress Syndrome. ARDSNet studies: ARMA, FACCT, and ALVEOLI Table of Contents to Fax from OHRP page 1 Oct. 7, 2002 OHRP letter to: Ronald S. Newvbower, Ph.D(Mass. General Hospital), Lee E. Limbird, Ph.D. (Vanderbilt University), and Robert Kay, MD) (Cleveland Clinic Foundation)…
Japan Links 81 Deaths to new Lung Cancer Drug Thu, 5 Dec 2002 Now a days, the fate of a drug depends not so much on its efficacy and safety, but rather on the financial needs of the manufacturer and the company’s ability to round up an “independent” panel of…
